Skip to content

Faculty profile

Philippe Boileau

Back to faculty
Faculty memberEpidemiology, Biostatistics and Occupational HealthMcGill University

Research

Read how they describe their research on their McGill University profile.

Latest papers

  • The Effect of Canagliflozin Dose on Renal and Cardiovascular Outcomes in Type 2 Diabetes and High Cardiovascular Risk.

    Diabetes, obesity & metabolism · 2026

  • Evaluating possible treatment effect heterogeneity in a randomized trial of milrinone versus dobutamine in cardiogenic shock.

    Critical care (London, England) · 2026

  • Guidance on individualized treatment rule estimation in high dimensions.

    The international journal of biostatistics · 2025 · first author

All 3 publications

Latest funding

  • Impact of Canagliflozin on peritoneal membrane function and integrity in patients with kidney failure on Peritoneal Dialysis

    CIHR · 2026 · Co-investigator

    $187,424
  • Enabling and Engaging patients to DECIDE indefinite versus short-term anticoagulation for VTE (DECIDE-VTE): A Stepped-Wedge Cluster Randomized Trial

    CIHR · 2025 · Co-investigator

    $589,052
All 2 grants and awards

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction